The Instand-NGS4P Kick-off meeting took place at the Medical University of Graz in Austria from the 30.-31. January 2020. More than 60
The publication of the Instand-NGS4P project presentation on the CORDIS News site will help to increase visibility and awareness of the project:
At the webinar on the Tendering Process, which was held on the 28th of April and was attended by up to 94 participants, Coordinator Kurt Zatloukal gave a presentation and answered questions about the project and the PCP process, including details regarding the evaluation criteria which should help potential solution providers prepare their bids. View
Virtual Open Market Consultation event attracts widespread interest The 2-day virtual Open Market Consultation event held on the 22nd and 23rd March 2021 attracted a large amount of interest and was attended by up to 178 registrants from 31 countries. Button: Read more (presentations available) Participants included stakeholders from industry (the biotech, bioinformatics and pharmaceutical
26 – 28 May 2021 We are pleased to draw your attention to this highly relevant conference taking place at the end of May, at which the Coordinator of Instand-NGS4P, Kurt Zatloukal, will be speaking on the pre-analytical requirements for in vitro diagnostic medical devices. DEADLINES Abstract submission deadline: April 30 2021 Registration deadline:
At the opening public session of the Instand-NGS4P Consortium Meeting, Ivo Gut (CNAG-CRG, Spain) and Sir Mark Caulfield (Genomics England) gave a fascinating insight into the impressive progress being made in the field of NGS in Healthcare: Ivo Gut talked about “Experiences with Good Genomic Practice”, and this was followed by Sir Mark Caulfield´s talk
Ivo Gut (CNAG-CRG, Spain) “Experiences with Good Genomic Practice” Sir Mark Caulfield (Genomics England, UK) “100,000 Genomes: Transforming healthcare” When: January 26th 2021, 13:00 – 14:50 CET Where: View the lectures here: https://drive.google.com/file/d/1AUk9jVM5Y0j897KbuLeSptw_IXp_Unxz/view?usp=sharing Attendance is free. A recording will be available on the project website after the event: https://www.instandngs4p.eu/ INSTAND-NGS4P is an EU-funded Pre-Commercial
CEN/TC 140 covers standardization in the field of in vitro diagnostic medical devices, and ISO/TC SC1 handles Genomics Informatics. The newly established liaisons with these two committees will enable the project to benefit from access to the relevant standards which are in development. Instand-NGS4P plans to submit a new work item proposal to CEN/TC 140
The EU-Instand-NGS4P project presentation at the Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO). The Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO) is a body of the Tuscany Regional Health Service whose purpose is to promote, measure and study primary, secondary and tertiary actions for cancer prevention and
In this YouTube video, Coordinator Kurt Zatloukal (Medical University of Graz) introduces the project and provides an overview of the background and aims.
Instand-NGS4P’s liaisons with the ISO Technical Committee ISO/TC 276/Working Groups 3 and 5 are now registered. This will help and promote NGS-related standardization project development without overlapping or conflicting requirements. Instand-NGS4P now has access to ongoing ISO activities, enabling the fulfilment of the project goals of – Analysis of existing standards – Analysis of standards
Challenges of bringing NGS to patients Article by Siliconrepublic.com 29 June 2020 Prof Kurt Zatloukal, Coordinator of the EU-funded Pre-Commercial Procurement project, Instand-NGS4P, talks to Siliconrepublic.com, a leading online publication in Europe focussing on vital issues impacting science, technology, engineering and maths. Prof. Zatloukal highlights in this interview the challenges facing the scientific community with